VIR
Vir Biotechnology Inc

6,333
Loading...
Loading...
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
408

Frequently Asked Questions

What is Market Cap of Vir Biotechnology Inc?
What is the 52-week high for Vir Biotechnology Inc?
What is the 52-week low for Vir Biotechnology Inc?
What is Vir Biotechnology Inc stock price today?
What was Vir Biotechnology Inc stock price yesterday?
What is the PE ratio of Vir Biotechnology Inc?
What is the Price-to-Book ratio of Vir Biotechnology Inc?
What is the 50-day moving average of Vir Biotechnology Inc?
How many employess does Vir Biotechnology Inc has?

Latest VIR News

View

Advertisement. Remove ads.

Advertisement. Remove ads.